Canopy Growth Corp is a cannabis company that produces, distributes, and sells a diverse range of cannabis and cannabis-related products for adult-use and medical purposes under a portfolio of distinct brands in Canada. The Company supplies cannabis products in Canada, Europe, and Australia.
It is a $360M healthcare company. Revenue shrank 15.1% over the last year, it currently loses money, and it holds more cash than debt.
- Website
- canopygrowth.com
- Location
- Smith Falls, A6
- Employees
- 1 128
- Sector
- Healthcare
- Founded
- 2013
Skills
Six independent scores, 0–100, built from reported numbers and valuation history. Click a row to see how it was scored.
Valuation, Growth, Profitability, Quality and Moat lag behind.
Valuation35
- P/E vs own historyn/a · 10/25
- FCF yield-19.2% · 0/25
- P/S1.8x · 25/25
- EV/EBITDA102.9x · 0/25
Growth0
- Revenue CAGR-15.1% · 0/25
- Net income CAGRn/a · 0/25
- EPS CAGR ~5Yn/a · 0/25
- Fwd implied growthn/a · 0/25
Profitability0
- ROIC-47.8% · 0/25
- ROE-32.8% · 0/25
- Net margin-92.4% · 0/25
- Operating margin-59.9% · 0/25
Health53
- Altman Z-13.41 · 3/25
- Current ratio3.04 · 25/25
- Interest coverage-12.1x · 0/25
- Net cash / debtNet cash · 25/25
Quality35
- Piotroski F4/9 · 10/25
- Beneish M-2.52 · 25/25
- FCF conversionn/a · 0/25
- Margin stabilityσ 389.0% · 0/25
Moat0
- ROIC >12% years0/6 yrs · 0/25
- Median gross margin2.2% · 0/25
- FCF-positive years0/6 yrs · 0/25
- Worst-year net marginworst -813.6% · 0/25
Experience
The company's career so far — founding, the IPO, landmark products and acquisitions, plus revenue milestones and insider buying.
- FY2023FinancialBecame debt-freecash now exceeds total debt
- 2019MilestoneCanopy was the world's largest cannabis company based on the value of all shares or market…
- 2019AcquisitionExpansion into Europe continued in April 2019 with the acquisition of licensed cannabis producer Cáñamo y Fibras…
- Oct 17, 2018MilestoneMarijuana became legal in Canada for recreational use
- Jul 10, 2018AcquisitionHiku was a recreational and medical cannabis company based in Toronto, Ontario and Kelowna, British Columbia which…
- Jan 27, 2017AcquisitionCanopy and Mettrum Health Corp. announced the takeover of Mettrum by Canopy
- 2016AcquisitionCanopy Growth Corp. announced a friendly takeover bid of another licensed Ontario-based…
- 2016MilestoneThe company was described as "Canada's first cannabis unicorn with a $1 billion dollar valuation" by the Financial…
- 2015MilestoneThe company was renamed to Canopy Growth Corp. in September 2015 with two established brands: Tweed Inc
- 2013FoundedTweed was founded by Bruce Linton and Chuck Rifici in 2013, and renamed Canopy Growth Corporation in 2015 after a…
Achievements
Verifiable track record, straight from the reported numbers.
Strengths & watch-outs
What a bull and a bear would each point to. Both lists come from the reported numbers, not opinions.
Strengths
- Net cash position after subtracting debt from cash
Watch-outs
- Revenue shrinking 15.1% year over year
- Not profitable — 92.4% net margin
- Negative free cash flow (-$69.1M)
- Altman Z-Score -13.41 — elevated financial-distress risk
- Thin interest coverage (-12.1×)
Qualifications
The basics a company should meet before you research it further. Each check uses the reported numbers.
- Revenue growing — the company sells more than a year ago-15.1% YoY
- Profitable — makes more than it spends-$263M TTM
- Profit growing — earnings are higher than last year+56.0% YoY
- Generates cash — cash left after running and investing-$69.1M TTM
- Debt under control — could handle its obligationsmore cash than debt
- Established company — not a micro-cap — lower blow-up risk$360M market cap
- Not printing shares — share count not ballooning — you keep your slice-14.3% shares over ~5y
- Proven track record — years of profitability behind it0/6 profitable years
- Financially stable — balance sheet not near distressAltman Z -13.4 — distress
- Pays a dividend — returns cash to shareholdersno data
- Valuation not extreme — price not wildly above earningsno data
Peer comparisonCanopy Growth Corporation vs 6 largest healthcare peers — cap, P/E, growth and margin side by sideOpen ▾Close ▴
| Company | Market cap | P/E | Revenue growth | Net margin | Profile |
|---|---|---|---|---|---|
| CGC this company | $360M | — | -15.1% | -92.4% | Mixed |
| LLY Eli Lilly & Co. | $1.0T | 41.6 | +49.6% | 33.5% | Solid |
| JNJ Johnson & Johnson | $630.9B | 29.9 | +8.1% | 21.5% | Mixed |
| ABBV Abbvie Inc. | $488.5B | 77.4 | +10.4% | 9.8% | Mixed |
| MRK Merck & Co., Inc. | $361.0B | 113.2 | +4.6% | 4.8% | Mixed |
| UNH UNITEDHEALTH GROUP INCORPORATED (Delaware) | $340.7B | 24.1 | +6.5% | 3.1% | Mixed |
| NVS Novartis AG | $273.2B | 20.3 | +9.6% | 24.7% | Solid |
Head-to-head: CGC vs LLY · CGC vs JNJ · CGC vs ABBV
References
What covering analysts publish about the company — information only, not a recommendation.
Appendix · Financial records
The full statements behind this CV, FY2020–FY2026. For readers who want to check the numbers.
Live data and quarterly detail: stockcv.com/CGC
Want the live picture — intraday moves, valuation history and full analysis?
Deeper analysis of CGC on PreMarketPriceFigures are derived from company filings (quarterly values normalised from as-filed year-to-date data where applicable) and may be delayed, restated or incomplete. This page is information, not investment advice. Latest price $0.84 · market cap $360M.